ISRCTN72367932已完成未知
Multicentre, randomised, double-blind trial comparing yellow fever vaccines from 17D and WHO 17DD-213/77 substrains in children
Bio-Manguinhos (Brazil)0 个研究点目标入组 3,500 人开始时间: 2006年2月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Children aged between 9 and 23 months, brought by their guardians to public health care units in regions where vaccination against yellow fever is recommended by the Brazilian National Program of Immunisation
排除标准
- •1. Severe malnutrition
- •2. Transitory or permanent immunodeficiency
- •3. Treatment with immunoglobulin or blood products
- •4. Administration of experimental drugs or vaccines in the previous 60 days or next 60 days of yellow fever vaccination
- •5. Hypersensitivity to chicken egg products or gelatin
- •6. Chronic or acute conditions constituting temporary contraindications to routine
- •7. Immunisation
- •8. Fever above 37.5°C
- •9. Mothers unwilling or unable to return 30 days after vaccination for blood collection
研究者
相似试验
已完成
不适用
Randomised double-blind multicentre trial comparing bilateral subthalamic nucleus deep brain stimulation and bilateral globus pallidus deep brain stimulation for advanced Parkinson's diseaseParkinson's diseaseNervous System DiseasesISRCTN85542074Academic Medical Centre (AMC) (Netherlands)128
招募中
不适用
A multicenter, randomized, controlled trial comparing the efficacy of oral fluoroquinolone and aminopenicillin with intravenous Cephalosporin in low-risk pediatric cancer patients with febrile neutropenia.JPRN-UMIN000006131Tokyo Metropolitan Children's Medical Center124
已完成
3 期
A multi-center, randomized controlled trial comparing early versus elective colonoscopy in outpatients with acute lower gastrointestinal bleedingAcute lower gastrointestinal bleedingJPRN-UMIN000021129Graduate School of Medicine, The University of Tokyo162
进行中（未招募）
Unknown
Reducing chronic breathlessness in adults by following a self-guided, internet-based supportive interventioAdults living with chronic breathlessness due to malignant and non-malignant diseasesRespiratoryISRCTN13121835King's College Hospital NHS Foundation Trust246
进行中（未招募）
1 期
A multicentre, randomised, double-blind, comparative trial of a novel CCR5 antagonist, UK427,857, in combination with zidovudine/lamivudine versus efavirenz in combination with zidovudine/lamivudine for the treatment of antiretroviral-naïve HIV-1 infected subjectsK-427,857 is an antagonist of the human chemokine receptor, and is intended to help prevent the development and progression of AIDS in indivuduals HIV-1 positive.MedDRA version: 14.1 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestationsEUCTR2004-001914-15-GBViiV Healthcare UK Limited891